シヨウダ　モリオ   SHODA Morio   庄田　守男    所属   医学部 医学科（東京女子医科大学病院）    職種   寄附部門教授
言語種別	英語
発表タイトル	Blood Urea Nitrogen to Albumin Ratio Predicts Mortality of Heart Failure Patients with Cardiac Resynchronization Therapy
会議名	The 81st Annual Scientific Meeting of the Japanese Circulation Society (JCS2017)
主催者	Japanese Circulation Society
学会区分	全国規模の学会
発表形式	ポスター掲示
講演区分	一般
発表者・共同発表者	◎KAWAKAMI Emiko, SUZUKI Atsushi, SHIGA Tsuyoshi, IWANAMI Yuji, HENMI Ryuta, YAGISHITA Daigo, EJIMA Koichiro, SUZUKI Tsuyoshi, SHODA Morio, HAGIWARA Nobuhisa
発表年月日	2017/03/19
開催地 （都市, 国名）	Kanazawa, JAPAN
学会抄録	PROGRAM JCS 2017 389
概要	Serum albumin and renal function play an important role in maintaining physiological homeostasis. The aim of this study is to evaluate the association between blood urea nitrogen to albumin (B/A) ratio before cardiac resynchronization therapy (CRT) implantation and mortality. We studied 391 patients who implanted CRT between 2002 to 2014. During 32 months of follow-up, 117 (30%) patients died from any cause. There was a significantly higher B/A ratio in dead patients than survived (p<0.05). 63% of CRT patients had decreased left ventricular end-systolic volume (LVESV) more than 15% after 6 months of CRT (responders). By cox regression analysis, independent risks for mortality were non-responder and high value of B/A ratio (Table). Our results suggested that B/A ratio is an independent predictor of mortality in HF patients treated by CRT.